magnesium sulfate has been researched along with HbS Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abas, AB; De Franceschi, L; Palaniappan, SK; Soe, HHK; Than, NN | 2 |
| Friedman, JN; Goldman, RD; Kirby-Allen, M; Mounstephen, W | 1 |
| Badaki-Makun, O; Brousseau, DC; Casper, TC; Dean, JM; Hillery, CA; Panepinto, JA; Scott, JP | 1 |
| LEHMANN, H | 1 |
| Ambrus, CM; Ambrus, JL; Bannerman, R; Bettigole, R; Friedman, S; Gastpar, H | 1 |
| Barreras, L; Diggs, LW | 1 |
| Cawein, MJ; Danzer, LA; Lappat, EJ; O'Neill, RP; Roach, T | 1 |
2 review(s) available for magnesium sulfate and HbS Disease
| Article | Year |
|---|---|
Magnesium for treating sickle cell disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Female; Humans; Hydroxyurea; Magnesium; Magnesium Sulfate; Male; Middle Aged; Randomized Controlled Trials as Topic; Young Adult | 2019 |
Magnesium for treating sickle cell disease.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Child; Child, Preschool; Humans; Hydroxyurea; Injections, Intravenous; Magnesium; Magnesium Sulfate; Middle Aged; Pain Measurement; Parents; Pyrrolidonecarboxylic Acid; Quality of Life; Randomized Controlled Trials as Topic | 2017 |
1 trial(s) available for magnesium sulfate and HbS Disease
| Article | Year |
|---|---|
Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
Topics: Adolescent; Analgesics; Anemia, Sickle Cell; Child; Child, Preschool; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Length of Stay; Magnesium Sulfate; Male; Pain Measurement; Treatment Outcome; Vasodilator Agents | 2013 |
5 other study(ies) available for magnesium sulfate and HbS Disease
| Article | Year |
|---|---|
Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Biomarkers; Cooperative Behavior; Cytokines; Emergency Service, Hospital; Hospitals, Pediatric; Hospitals, Special; Humans; Hypotension; Informed Consent; Infusions, Intravenous; Interdisciplinary Communication; Interprofessional Relations; Length of Stay; Magnesium Sulfate; Narcotics; Pain; Quality of Life; Randomized Controlled Trials as Topic; Vasodilator Agents | 2014 |
Treatment of sickle-cell anemia.
Topics: Alkalies; Anemia; Anemia, Sickle Cell; Erythrocytes, Abnormal; Humans; Magnesium; Magnesium Sulfate | 1963 |
Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
Topics: Anemia, Sickle Cell; Animals; Macaca; Magnesium Sulfate; Male; Pentoxifylline; Platelet Aggregation; Theobromine | 1979 |
Sodium citrate orally for painful sickle cell crises.
Topics: Acetazolamide; Adult; Ammonium Chloride; Anemia, Sickle Cell; Bicarbonates; Citrates; Codeine; Fever; Humans; Hydrogen-Ion Concentration; Lactates; Magnesium Sulfate; Male; Pain; Parenteral Nutrition; Sodium; Water-Electrolyte Balance | 1971 |
A study of the sickling phenomenon and oxygen dissociation curve in patients with hemoglobins SS, SD, SF and SC.
Topics: Agar; Anemia, Sickle Cell; Carbonates; Cellulose; Electrophoresis; Fetal Hemoglobin; Glucosephosphate Dehydrogenase; Hemoglobinometry; Hemoglobins, Abnormal; Humans; Magnesium Sulfate; Oxygen Consumption; Sodium | 1969 |